Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 4314K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Detmer, S. A. Articles by Chan, D. C. Search for Related Content PubMed PubMed Citation Articles by Detmer, S. A. Articles by Chan, D. C. Related Collections Related Article Social Bookmarking                            What's this?

Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations

Division of Biology, California Institute of Technology, Pasadena, CA 91125

Correspondence to David C. Chan: dchan{at}caltech.edu

Mfn2, an oligomeric mitochondrial protein important for mitochondrial fusion, is mutated in Charcot-Marie-Tooth disease (CMT) type 2A, a peripheral neuropathy characterized by axonal degeneration. In addition to homooligomeric complexes, Mfn2 also associates with Mfn1, but the functional significance of such heterooligomeric complexes is unknown. Also unknown is why Mfn2 mutations in CMT2A lead to cell type–specific defects given the widespread expression of Mfn2. In this study, we show that homooligomeric complexes formed by many Mfn2 disease mutants are nonfunctional for mitochondrial fusion. However, wild-type Mfn1 complements mutant Mfn2 through the formation of heterooligomeric complexes, including complexes that form in trans between mitochondria. Wild-type Mfn2 cannot complement the disease alleles. Our results highlight the functional importance of Mfn1–Mfn2 heterooligomeric complexes and the close interplay between the two mitofusins in the control of mitochondrial fusion. Furthermore, they suggest that tissues with low Mfn1 expression are vulnerable in CMT2A and that methods to increase Mfn1 expression in the peripheral nervous system would benefit CMT2A patients.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

Pro-diversity mitofusins

Nicole LeBrasseur
J. Cell Biol. 2007 176: 373a. [Full Text] [PDF]

This article has been cited by other articles:

• Amiott, E. A., Cohen, M. M., Saint-Georges, Y., Weissman, A. M., Shaw, J. M. (2009). A Mutation Associated with CMT2A Neuropathy Causes Defects in Fzo1 GTP Hydrolysis, Ubiquitylation, and Protein Turnover. Mol. Biol. Cell 20: 5026-5035 [Abstract] [Full Text]  
• Liesa, M., Palacin, M., Zorzano, A. (2009). Mitochondrial Dynamics in Mammalian Health and Disease. Physiol. Rev. 89: 799-845 [Abstract] [Full Text]  
• Bo, R. D., Moggio, M., Rango, M., Bonato, S., D'Angelo, M. G., Ghezzi, S., Airoldi, G., Bassi, M. T., Guglieri, M., Napoli, L., Lamperti, C., Corti, S., Federico, A., Bresolin, N., Comi, G. P. (2008). Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 71: 1959-1966 [Abstract] [Full Text]  
• Arnold, S., de Araujo, G. W., Beyer, C. (2008). Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J Mol Endocrinol 41: 289-300 [Abstract] [Full Text]  
• Detmer, S. A., Velde, C. V., Cleveland, D. W., Chan, D. C. (2008). Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet 17: 367-375 [Abstract] [Full Text]  
• Baloh, R. H. (2008). Mitochondrial Dynamics and Peripheral Neuropathy. Neuroscientist 14: 12-18 [Abstract]  
• Jahani-Asl, A., Cheung, E. C. C., Neuspiel, M., MacLaurin, J. G., Fortin, A., Park, D. S., McBride, H. M., Slack, R. S. (2007). Mitofusin 2 Protects Cerebellar Granule Neurons against Injury-induced Cell Death. J. Biol. Chem. 282: 23788-23798 [Abstract] [Full Text]  
• Shen, T., Zheng, M., Cao, C., Chen, C., Tang, J., Zhang, W., Cheng, H., Chen, K.-H., Xiao, R.-P. (2007). Mitofusin-2 Is a Major Determinant of Oxidative Stress-mediated Heart Muscle Cell Apoptosis. J. Biol. Chem. 282: 23354-23361 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents